-
1
-
-
0023233060
-
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
-
T.A. Stamey, N. Yang, A.R. Hay, J.E. McNeal, F.S. Freiha, and E. Redwine Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
-
(1987)
N Engl J Med
, vol.317
, pp. 909-916
-
-
Stamey, T.A.1
Yang, N.2
Hay, A.R.3
McNeal, J.E.4
Freiha, F.S.5
Redwine, E.6
-
2
-
-
0029799835
-
Predictive properties of serum-prostate-specific antigen testing in a community-based setting
-
S.J. Jacobsen, E.J. Bergstralh, and H.A. Guess et al. Predictive properties of serum-prostate-specific antigen testing in a community-based setting Arch Intern Med 156 1996 2462 2468
-
(1996)
Arch Intern Med
, vol.156
, pp. 2462-2468
-
-
Jacobsen, S.J.1
Bergstralh, E.J.2
Guess, H.A.3
-
3
-
-
70349667018
-
A systematic review of the diagnostic accuracy of prostate specific antigen
-
P. Harvey, A. Basuita, D. Endersby, B. Curtis, A. Iacovidou, and M. Walker A systematic review of the diagnostic accuracy of prostate specific antigen BMC Urol 9 2009 14
-
(2009)
BMC Urol
, vol.9
, pp. 14
-
-
Harvey, P.1
Basuita, A.2
Endersby, D.3
Curtis, B.4
Iacovidou, A.5
Walker, M.6
-
4
-
-
21444447966
-
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
-
I.M. Thompson, D.P. Ankerst, and C. Chi et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66 70
-
(2005)
JAMA
, vol.294
, pp. 66-70
-
-
Thompson, I.M.1
Ankerst, D.P.2
Chi, C.3
-
5
-
-
2442715038
-
Prevalence of prostate cancer among men with a prostate-specific antigen level
-
I.M. Thompson, D.K. Pauler, and P.J. Goodman et al. Prevalence of prostate cancer among men with a prostate-specific antigen level N Engl J Med 350 2004 2239 2246
-
(2004)
N Engl J Med
, vol.350
, pp. 2239-2246
-
-
Thompson, I.M.1
Pauler, D.K.2
Goodman, P.J.3
-
7
-
-
78649362120
-
EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease
-
A. Heidenreich, J. Bellmunt, and M. Bolla et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61 71
-
(2011)
Eur Urol
, vol.59
, pp. 61-71
-
-
Heidenreich, A.1
Bellmunt, J.2
Bolla, M.3
-
8
-
-
0034644185
-
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland
-
P. Lichtenstein, N.V. Holm, and P.K. Verkasalo et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
-
(2000)
N Engl J Med
, vol.343
, pp. 78-85
-
-
Lichtenstein, P.1
Holm, N.V.2
Verkasalo, P.K.3
-
9
-
-
84868599480
-
Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial
-
A.K. Kader, J. Sun, and B.H. Reck et al. Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial Eur Urol 62 2012 953 961
-
(2012)
Eur Urol
, vol.62
, pp. 953-961
-
-
Kader, A.K.1
Sun, J.2
Reck, B.H.3
-
10
-
-
84856380174
-
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men
-
R.J. Klein, C. Hallden, and A. Gupta et al. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men Eur Urol 61 2012 471 477
-
(2012)
Eur Urol
, vol.61
, pp. 471-477
-
-
Klein, R.J.1
Hallden, C.2
Gupta, A.3
-
11
-
-
84872931195
-
Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: Results from a population-based study, 2003-2011
-
T. Nordström, M. Aly, M.S. Clements, C.E. Weibull, J. Adolfsson, and H. Grönberg Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003-2011 Eur Urol 63 2013 419 425
-
(2013)
Eur Urol
, vol.63
, pp. 419-425
-
-
Nordström, T.1
Aly, M.2
Clements, M.S.3
Weibull, C.E.4
Adolfsson, J.5
Grönberg, H.6
-
12
-
-
79957946061
-
Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 cohort study
-
M. Aly, F. Wiklund, and J. Xu et al. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study Eur Urol 60 2011 21 28
-
(2011)
Eur Urol
, vol.60
, pp. 21-28
-
-
Aly, M.1
Wiklund, F.2
Xu, J.3
-
13
-
-
24144493035
-
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
-
J.I. Epstein, W.C.J. Allsbrook, M.B. Amin, and L.L. Egevad The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242
-
(2005)
Am J Surg Pathol
, vol.29
, pp. 1228-1242
-
-
Epstein, J.I.1
Allsbrook, W.C.J.2
Amin, M.B.3
Egevad, L.L.4
-
14
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
-
discussion 207-12
-
M.J. Pencina, R.B.S. D'Agostino, R.B.J. D'Agostino, and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12
-
(2008)
Stat Med
, vol.27
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino, R.B.S.2
D'Agostino, R.B.J.3
Vasan, R.S.4
-
15
-
-
63449085837
-
Utility of incorporating genetic variants for the early detection of prostate cancer
-
R.K. Nam, W.W. Zhang, and J. Trachtenberg et al. Utility of incorporating genetic variants for the early detection of prostate cancer Clin Cancer Res 15 2009 1787 1793
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1787-1793
-
-
Nam, R.K.1
Zhang, W.W.2
Trachtenberg, J.3
-
16
-
-
84856380113
-
Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators
-
M.J. Roobol, H.A. van Vugt, and S. Loeb et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators Eur Urol 61 2012 577 583
-
(2012)
Eur Urol
, vol.61
, pp. 577-583
-
-
Roobol, M.J.1
Van Vugt, H.A.2
Loeb, S.3
-
17
-
-
79960924160
-
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
-
Z. Kote-Jarai, A.A. Olama Al, and G.G. Giles et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study Nat Genet 43 2011 785 791
-
(2011)
Nat Genet
, vol.43
, pp. 785-791
-
-
Kote-Jarai, Z.1
Olama Al, A.A.2
Giles, G.G.3
-
18
-
-
39749159112
-
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer
-
J. Gudmundsson, P. Sulem, and T. Rafnar et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer Nat Genet 40 2008 281 283
-
(2008)
Nat Genet
, vol.40
, pp. 281-283
-
-
Gudmundsson, J.1
Sulem, P.2
Rafnar, T.3
-
19
-
-
70349545839
-
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
-
R.A. Eeles, Z. Kote-Jarai, and A.A. Olama Al et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Nat Genet 41 2009 1116 1121
-
(2009)
Nat Genet
, vol.41
, pp. 1116-1121
-
-
Eeles, R.A.1
Kote-Jarai, Z.2
Olama Al, A.A.3
-
20
-
-
77956637724
-
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
-
R. Takata, S. Akamatsu, and M. Kubo et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population Nat Genet 42 2010 751 754
-
(2010)
Nat Genet
, vol.42
, pp. 751-754
-
-
Takata, R.1
Akamatsu, S.2
Kubo, M.3
-
21
-
-
80052716147
-
Genome-wide association study identifies new prostate cancer susceptibility loci
-
F.R. Schumacher, S.I. Berndt, and A. Siddiq et al. Genome-wide association study identifies new prostate cancer susceptibility loci Hum Mol Genet 20 2011 3867 3875
-
(2011)
Hum Mol Genet
, vol.20
, pp. 3867-3875
-
-
Schumacher, F.R.1
Berndt, S.I.2
Siddiq, A.3
-
22
-
-
70349547128
-
Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility
-
J. Gudmundsson, P. Sulem, and D.F. Gudbjartsson et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility Nat Genet 41 2009 1122 1126
-
(2009)
Nat Genet
, vol.41
, pp. 1122-1126
-
-
Gudmundsson, J.1
Sulem, P.2
Gudbjartsson, D.F.3
-
23
-
-
39749129053
-
Multiple newly identified loci associated with prostate cancer susceptibility
-
R.A. Eeles, Z. Kote-Jarai, and G.G. Giles et al. Multiple newly identified loci associated with prostate cancer susceptibility Nat Genet 40 2008 316 321
-
(2008)
Nat Genet
, vol.40
, pp. 316-321
-
-
Eeles, R.A.1
Kote-Jarai, Z.2
Giles, G.G.3
-
24
-
-
39749118602
-
Multiple loci identified in a genome-wide association study of prostate cancer
-
G. Thomas, K.B. Jacobs, and M. Yeager et al. Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 40 2008 310 315
-
(2008)
Nat Genet
, vol.40
, pp. 310-315
-
-
Thomas, G.1
Jacobs, K.B.2
Yeager, M.3
-
25
-
-
33745169697
-
A common variant associated with prostate cancer in European and African populations
-
L.T. Amundadottir, P. Sulem, and J. Gudmundsson et al. A common variant associated with prostate cancer in European and African populations Nat Genet 38 2006 652 658
-
(2006)
Nat Genet
, vol.38
, pp. 652-658
-
-
Amundadottir, L.T.1
Sulem, P.2
Gudmundsson, J.3
-
26
-
-
70349548806
-
Multiple loci on 8q24 associated with prostate cancer susceptibility
-
A.A. Olama Al, Z. Kote-Jarai, and G.G. Giles et al. Multiple loci on 8q24 associated with prostate cancer susceptibility Nat Genet 41 2009 1058 1060
-
(2009)
Nat Genet
, vol.41
, pp. 1058-1060
-
-
Olama Al, A.A.1
Kote-Jarai, Z.2
Giles, G.G.3
-
27
-
-
34247563453
-
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
-
J. Gudmundsson, P. Sulem, and A. Manolescu et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat Genet 39 2007 631 637
-
(2007)
Nat Genet
, vol.39
, pp. 631-637
-
-
Gudmundsson, J.1
Sulem, P.2
Manolescu, A.3
-
29
-
-
34547510624
-
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
-
J. Gudmundsson, P. Sulem, and V. Steinthorsdottir et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat Genet 39 2007 977 983
-
(2007)
Nat Genet
, vol.39
, pp. 977-983
-
-
Gudmundsson, J.1
Sulem, P.2
Steinthorsdottir, V.3
-
30
-
-
52949115663
-
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12
-
J. Sun, S.L. Zheng, and F. Wiklund et al. Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12 Nat Genet 40 2008 1153 1155
-
(2008)
Nat Genet
, vol.40
, pp. 1153-1155
-
-
Sun, J.1
Zheng, S.L.2
Wiklund, F.3
-
31
-
-
79959731094
-
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript
-
Z. Kote-Jarai, A. Amin Al Olama, and D. Leongamornlert et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript Hum Genet 129 2011 687 694
-
(2011)
Hum Genet
, vol.129
, pp. 687-694
-
-
Kote-Jarai, Z.1
Amin Al Olama, A.2
Leongamornlert, D.3
-
32
-
-
58249121582
-
Sequence variants at 22q13 are associated with prostate cancer risk
-
J. Sun, S.L. Zheng, and F. Wiklund et al. Sequence variants at 22q13 are associated with prostate cancer risk Cancer Res 69 2009 10 15
-
(2009)
Cancer Res
, vol.69
, pp. 10-15
-
-
Sun, J.1
Zheng, S.L.2
Wiklund, F.3
|